
Sign up to save your podcasts
Or
Credits: 0.50 AMA PRA Category 1 Credit™
Overview: This in-depth discussion provides guidance on the options available to clinicians for managing potential drug-drug interactions in non-hospitalized patients with COVID-19. Hear practical strategies for increased monitoring, dosage adjustments, and exploring alternative medications to enable the safe use of anti-COVID-19 therapies. Faculty also discuss when consultation with a pharmacist and/or patient’s specialist is advised.
4.5
8383 ratings
Credits: 0.50 AMA PRA Category 1 Credit™
Overview: This in-depth discussion provides guidance on the options available to clinicians for managing potential drug-drug interactions in non-hospitalized patients with COVID-19. Hear practical strategies for increased monitoring, dosage adjustments, and exploring alternative medications to enable the safe use of anti-COVID-19 therapies. Faculty also discuss when consultation with a pharmacist and/or patient’s specialist is advised.
494 Listeners
688 Listeners
282 Listeners
278 Listeners
255 Listeners
3,324 Listeners
1,113 Listeners
717 Listeners
193 Listeners
290 Listeners
514 Listeners
249 Listeners
364 Listeners
228 Listeners
315 Listeners